#supremecourt – Family Life Podcasts

Doctors vs the FDA: A Supreme Court decision on mail-order Mifepristone – 6/27/24

By Family Life News | June 27, 2024

Podcast: Play in new window | Download (Duration: 7:09 — 9.8MB)

Subscribe: Apple Podcasts | Android | Email | RSS

Dr. Ingrid Skop was interviewed for the Family Life Noon Report, with a pro-life OB-GYN’s perspective on the recent Supreme Court decision saying the “Hippocratic Medicine” group was not the right plaintiff to bring suit against the Federal Food and Drug Administration.

Previous Family Life Interviews:

Attorney Katie Daniel of Susan B. Anthony Prolife America gave us initial reaction to this Supreme Court decision, why the justices’ ruling does not end this issue against the FDA, and what the next steps will be: 6/24/2024

Dr. Ingrid Skop spoke with us, as this case was being decided by the U.S. Court of Appeals: 6/01/2023

Dr. Ingrid Skop, in a Family Life Interview, about the harm many patients are suffering, because of the unchecked side effects of the abortion-triggering drug Mifepristone: 4/25/2023

Family Life’s weekly Pennsylvania and New York roundtable frequently discussed the matters surrounding the prevalence of these abortion pills, increasingly without a doctor’s supervision and care: scroll through Capital Connection archives

SCOTUS ruling on FDA “Mail-Order Mifepristone” – 6/24/24

By Family Life News | June 24, 2024

Podcast: Play in new window | Download (Duration: 8:39 — 11.9MB)

Subscribe: Apple Podcasts | Android | Email | RSS

A Special Family Life Interview

The U.S. Supreme Court, at least temporarily, has allowed continued mail-order distribution of abortion-inducing pills. A group of pro-life physicians had sued to stop the practice, after FDA regulations were revised to eliminate a requirement to meet with a doctor before starting the process to end the pregnancy. The latest FDA rules say even a video visit with a prescriber is no longer needed.

Opponents of widespread use of the two-pill “cocktail” of Mifepristone and Misoprostal quote the FDA’s own statistics that 1 of every 25 women who take these drugs end up in an emergency department with complications. Other physical and emotional-health consequences are likely more numerous.

Attorney Katie Daniel of Susan B. Anthony Pro-Life America gave Family Life News her reaction to the SCOTUS decision, predictions on where the case goes next, and why these pills can be so harmful to women, especially with no required followup with a medical professional.

For further information:

More from Katie Daniel: In-depth polling, conducted by CRC Research for Susan B. Anthony Pro-Life America, reveals that 75% of Americans believe the FDA should have performed studies focused on girls under the age of 18 before approving these pills for minors.
Susan B. Anthony Pro-Life America: That organizations official website
SBA on WPLG: Women’s safety, in light of sexual trafficking and domestic abusers
Click the picture of the Court building to read the full June 13 decision.